Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)
China flag China · Delayed Price · Currency is CNY
31.20
-0.98 (-3.05%)
Jul 30, 2026, 3:04 PM CST

SHE:300584 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
44.3842.0640.2236.3232.45285.88
Depreciation & Amortization
64.4764.4752.9353.5648.1437.06
Other Amortization
0.120.12---0.01
Loss (Gain) From Sale of Assets
-0.48-0.48-0.790.950.02
Asset Writedown & Restructuring Costs
4.44.42.090.040.922.56
Loss (Gain) From Sale of Investments
26.2926.29-0-0.06-1.05-306.42
Provision & Write-off of Bad Debts
0.370.37-0.851.654.07-
Other Operating Activities
-22.7712.116.9212.9611.156.51
Change in Accounts Receivable
-70.77-70.77-49.87-31.52-121.75-37.4
Change in Inventory
2.262.26-13.44-22-9.3717.48
Change in Accounts Payable
11.6811.6817.76-19.3357.1216.15
Operating Cash Flow
45.5478.0959.9623.93-5.8259.94
Operating Cash Flow Growth
-53.73%30.23%150.54%---18.32%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-48.6-62.64-77.94-197.22-218.94-94.41
Sale of Property, Plant & Equipment
29.5329.50.010.650.080.04
Investment in Securities
--8.1059.31247.988.8
Investing Cash Flow
-19.07-41.24-77.93-137.2729.12-85.57

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-18.673.629.38283.97145
Long-Term Debt Issued
-234.3273.5305.24949.18
Total Debt Issued
235.4252.9347.1334.58332.97194.18
Short-Term Debt Repaid
--60.36-73.47---135
Long-Term Debt Repaid
--222.97-260.1-263.04-338.55-0.08
Total Debt Repaid
-261.12-283.33-333.57-263.04-338.55-135.08
Net Debt Issued (Repaid)
-25.72-30.4313.5371.54-5.5859.1
Common Dividends Paid
-19.32-19.5-13.85-6.47-35.5-22.02
Other Financing Activities
38.5533.517.24--0.95-
Financing Cash Flow
-6.48-16.4316.9165.07-42.0337.08

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
00.02-0.010.020.01-0.06
Net Cash Flow
19.9920.43-1.06-48.25-18.7311.39

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-3.0615.45-17.98-173.29-224.76-34.47
Free Cash Flow Growth
------
Free Cash Flow Margin
-0.44%2.30%-3.56%-33.46%-42.69%-5.96%
Free Cash Flow Per Share
-0.030.13-0.15-1.44-1.87-0.29
Levered Free Cash Flow
54.6285.37-15.15-176.9-232.921.51
Unlevered Free Cash Flow
58.5889.53-9.54-171.73-228.3626.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
93.3482.2546.5482.7967.1883.26
Change in Working Capital
-71.24-71.24-51.34-81.32-102.4534.31